Cargando…
Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
Shenmai injection (SMI), as a patented traditional Chinese medicine, is extracted from Panax ginseng and Ophiopogon japonicus. It commonly used in the treatment of cardiovascular disease and in the control of cardiac toxicity induced by doxorubicin (DOX) treatment. However, its anti-cardiotoxicity m...
Autores principales: | Li, Lin, Li, Jinghao, Wang, Qilong, Zhao, Xin, Yang, Dongli, Niu, Lu, Yang, Yanze, Zheng, Xianxian, Hu, Limin, Li, Yuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289952/ https://www.ncbi.nlm.nih.gov/pubmed/32581790 http://dx.doi.org/10.3389/fphar.2020.00815 |
Ejemplares similares
-
Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
por: Li, Lin, et al.
Publicado: (2020) -
Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
por: Zhang, Sheng, et al.
Publicado: (2019) -
Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023) -
Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
por: Wang, Shao-mei, et al.
Publicado: (2020) -
Quality monitoring of Shenmai injection by HPLC pharmacodynamic fingerprinting
por: Yang, Geng, et al.
Publicado: (2023)